Pharmaceutical

Evaxion Biotech to develop new vaccines for cancer

Evaxion Biotech has announced plans to develop customised cancer vaccines by targeting a category of AI-discovered tumour antigens.

Jan 25, 2024 - 18:00
Evaxion Biotech to develop new vaccines for cancer
Evaxion Biotech has announced plans to develop customised cancer vaccines by targeting a category of AI-discovered tumour antigens.
Read the original article

Tags:

Previous Article

Harnessing the untapped potential of medicines access 

Next Article

Kyowa Kirin acquires Orchard Therapeutics for $477.6m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Chamber of Commerce, government clash at first court hearing on Medicare drug prices

STAT+: Chamber of Commerce, government clash at first c...

Sep 16, 2023

STAT+: Eli Lilly to acquire Versanis in heated race for weight loss drugs

STAT+: Eli Lilly to acquire Versanis in heated race for...

Jul 14, 2023

FDA accepts Takeda’s NDA resubmission for eosinophilic esophagitis therapy

FDA accepts Takeda’s NDA resubmission for eosinophilic ...

Sep 21, 2023